Jalal Abdolalizadeh

Dr. Jalal Abdolalizadeh


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2016 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
RRRamin Raoufinia
Ramin Raoufinia
AMAli Mota
Ali Mota
NKNeda Keyhanvar
Neda Keyhanvar
FSFatemeh Safari
Fatemeh Safari
SSSara Shamekhi
Sara Shamekhi
JAJalal Abdolalizadeh
Jalal Abdolalizadeh
Overview of Albumin and Its Purification Methods

10 November 2020 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
MVMehdi A. Vostakolaei
Mehdi A. Vostakolaei
LHLeila Hatami‐Baroogh
Leila Hatami‐Baroogh
GBGhader Babaei
Ghader Babaei
OMOmmoleila Molavi
Ommoleila Molavi
SKShirafkan Kordi
Shirafkan Kordi
JAJalal Abdolalizadeh
Jalal Abdolalizadeh

1 March 2020 in Advances in Medical Sciences
Verified
Journal Article
Closed access
JMJavad Masoumi
Javad Masoumi
AJAbdollah Jafarzadeh
Abdollah Jafarzadeh
HKHossein Khorramdelazad
Hossein Khorramdelazad
MAMorteza Abbasloui
Morteza Abbasloui
JAJalal Abdolalizadeh
Jalal Abdolalizadeh
NJNajmeh Jamali
Najmeh Jamali

1 August 2018 in Neuropeptides
Verified
Journal Article
Closed access
JMJavad Masoumi
Javad Masoumi
MAMorteza Abbasloui
Morteza Abbasloui
RPReza Parvan
Reza Parvan
DMDaryoush Mohammadnejad
Daryoush Mohammadnejad
Graciela Pavon-DjavidGraciela Pavon-Djavid
Graciela Pavon-Djavid
JAJalal Abdolalizadeh
Jalal Abdolalizadeh

19 August 2009 in Human Antibodies
Verified
Journal Article
Closed access
PDF file
JMJafar Majidi
Jafar Majidi
JBJaleh Barar
Jaleh Barar
Behzad BaradaranBehzad Baradaran
Behzad Baradaran
JAJalal Abdolalizadeh
Jalal Abdolalizadeh
YOYadollah Omidi
Yadollah Omidi
In the past decades, the mainstay of systemic therapy for solid and haematological malignancies was chemotherapy; nevertheless this modality has the drawbacks such as drug resistance and eliciting sever cytotoxicity in the normal tissue. To resolve s

1 July 2019 in Ultrasonics Sonochemistry
Verified
Journal Article
Open access
SSS. Mohamadi Saani
S. Mohamadi Saani
JAJalal Abdolalizadeh
Jalal Abdolalizadeh
SHSaeed Zeinali Heris
Saeed Zeinali Heris
Delivery of drugs and active agents to human skin by formulation containing nanosystems have shown remarkable advance in recent nanotechnology research. The aim of current investigation is to study protein drug, extracted from medicinal leech tissue and evaluate an isotropic and kinetically stable nanoemulsion formulation, with least surfactant and co-surfactant concentrations also with optimal solubility and stability, for topical delivery. It is a fact that physical properties of oil phase has an impact on nanoemulsion formation and stabilization. In this research, various factors, such as oil types (olive oil and sesame oil) and oil content for their effects on particle size and stability of protein nanoemulsion were first investigated. Secondly, optimized formulation of protein nanoemulsion was characterized by droplet size and zeta potential analysis, Transmission electron microscopy (TEM), viscosity, pH, and refractive index. Thirdly, stability studies were done to select the best formulation. The results of our experiments showed that an increase in the concentration of olive oil and sesame oil led to a nanoemulsion with smaller size of droplets and with higher stability, respectively. However; slight variations in droplet size were observed in case of nanoemulsion with olive oil. As a result of various experiments, a Nanoemulsion with 25% olive oil was selected as optimized formulation owing to its much smaller droplet size (143.1 nm), lower polydispersity index, higher zeta potential (-33.3 mV). No considerable changes in droplet size, viscosity and pH occurred during a 30-day storage period at 4 °C. This procedure also suggested that our selected nanoemulsion was physically stable. Additionally, TEM revealed that particles were morphologically spherical. In conclusion, our analyses of the experiments proved the fact that nanoemulsions are promising novel formulations for protein drugs and can greatly enhance stability of protein drugs.